0,983  0,002  Chemoprotective
0,982  0,001  Antimutagenic
0,958  0,002  Monophenol monooxygenase inhibitor
0,947  0,003  TNF expression inhibitor
0,944  0,002  Genotoxic
0,943  0,002  NOS2 expression inhibitor
0,942  0,002  UGT1A9 substrate
0,937  0,002  Caspase 9 stimulant
0,932  0,003  Antihypercholesterolemic
0,924  0,003  Chemopreventive
0,926  0,005  Alpha-glucosidase inhibitor
0,920  0,001  Antihypoxic
0,915  0,001  Melanin inhibitor
0,912  0,004  Mutagenic
0,909  0,002  Sulfotransferase substrate
0,908  0,001  Amylase inhibitor
0,905  0,002  Xanthine oxidase inhibitor
0,900  0,002  UGT1A1 substrate
0,901  0,004  Antioxidant
0,888  0,002  Proliferative diseases treatment
0,888  0,007  Transcription factor NF kappa B inhibitor
0,864  0,004  Cytostatic
0,862  0,003  Cardioprotectant
0,860  0,005  Cyclophilin D inhibitor
0,860  0,005  Antidiabetic
0,854  0,004  Radioprotector
0,853  0,005  Carcinogenic
0,847  0,004  Free radical scavenger
0,848  0,009  Antiinflammatory
0,839  0,012  Apoptosis agonist
0,822  0,004  Vasodilator, coronary
0,810  0,003  Mediator release inhibitor
0,807  0,004  UGT1A6 substrate
0,806  0,004  NOS3 expression inhibitor
0,803  0,009  Teratogen
0,793  0,002  Cystathionine beta-synthase inhibitor
0,784  0,004  Hypoglycemic
0,777  0,004  Angiogenesis stimulant
0,775  0,004  UDP-glucuronosyltransferase substrate
0,773  0,004  Histamine release inhibitor
0,763  0,010  Embryotoxic
0,752  0,002  Beta glucuronidase inhibitor
0,743  0,004  DNA damaging
0,733  0,002  Antihemorrhagic
0,730  0,005  AR expression inhibitor
0,720  0,005  Caspase 3 stimulant
0,722  0,007  Antibacterial
0,701  0,006  Nitric oxide antagonist
0,699  0,004  Skin whitener
0,685  0,006  Antiparasitic
0,667  0,006  Hepatic disorders treatment
0,670  0,010  Antithrombotic
0,664  0,005  Apoptosis antagonist
0,661  0,004  NOS3 expression enhancer
0,659  0,005  Vascular (periferal) disease treatment
0,667  0,015  CYP2C9 substrate
0,657  0,005  Antihelmintic
0,651  0,003  VCAM1 expression inhibitor
0,665  0,017  Antileukemic
0,648  0,006  Amyloid beta aggregation inhibitor
0,645  0,004  Hepatoprotectant
0,638  0,002  Protein kinase stimulant
0,635  0,003  Carbonic anhydrase XIII inhibitor
0,640  0,010  CTGF expression inhibitor
0,635  0,006  Antiamyloidogenic
0,651  0,023  CYP3A4 substrate
0,640  0,014  Cholesterol antagonist
0,626  0,003  Neurotrophic factor enhancer
0,628  0,012  CYP2C19 substrate
0,620  0,005  Antihypertriglyceridemic
0,617  0,005  Antineoplastic (osteosarcoma)
0,623  0,013  Sensitization
0,620  0,010  Cytotoxic
0,613  0,003  UGT2B4 substrate
0,617  0,008  Antipyretic
0,614  0,010  Antipruritic, allergic
0,610  0,012  Spasmolytic
0,603  0,007  Tumour necrosis factor alpha release inhibitor
0,625  0,031  Antineoplastic (breast cancer)
0,598  0,004  Aldehyde dehydrogenase inhibitor
0,593  0,004  Antihypotensive
0,601  0,017  Respiratory analeptic
0,585  0,003  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,588  0,008  Hypoxia-inducible factor 1 alpha inhibitor
0,606  0,029  Antineoplastic (lung cancer)
0,583  0,006  RNA-directed DNA polymerase inhibitor
0,576  0,004  Cyclic AMP phosphodiesterase inhibitor
0,586  0,016  5 Hydroxytryptamine release stimulant
0,566  0,002  Antihelmintic (Trematoda)
0,569  0,005  ICAM1 expression inhibitor
0,564  0,003  AMP-activated protein kinase stimulant
0,580  0,019  Immunostimulant
0,574  0,015  5 Hydroxytryptamine release inhibitor
0,551  0,004  Alkylator
0,545  0,003  Antifungal enhancer
0,539  0,004  Antidote
0,547  0,015  Ulceration
0,534  0,005  Non-steroidal antiinflammatory agent
0,557  0,028  Antineoplastic (colorectal cancer)
0,542  0,015  Antifungal
0,535  0,013  Antiprotozoal (Leishmania)
0,519  0,004  UGT2B15 substrate
0,514  0,002  Nitric-oxide synthase stimulant
0,513  0,002  DNA repair enzyme inhibitor
0,511  0,005  Lipid peroxidase inhibitor
0,520  0,017  Antineoplastic (brain cancer)
0,507  0,006  Interferon gamma antagonist
0,501  0,003  Cyclooxygenase 3 inhibitor
0,502  0,004  Hemostatic
0,502  0,004  Antitussive
0,517  0,020  Antineoplastic (cervical cancer)
0,521  0,024  Stroke treatment
0,499  0,002  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,508  0,011  Vasodilator
0,503  0,007  Radiosensitizer
0,525  0,030  Antineoplastic (colon cancer)
0,520  0,029  Prostate cancer treatment
0,494  0,004  Interleukin 4 antagonist
0,507  0,021  Antineoplastic (pancreatic cancer)
0,513  0,029  Immunosuppressant
0,492  0,009  Antineoplastic (sarcoma)
0,486  0,005  Platelet adhesion inhibitor
0,483  0,003  Carbonic anhydrase III inhibitor
0,492  0,013  Antineoplastic (lymphoma)
0,482  0,004  Aldose reductase substrate
0,490  0,014  DNA synthesis inhibitor
0,491  0,017  Antidiabetic (type 2)
0,484  0,011  Myocardial infarction treatment
0,475  0,007  Topoisomerase II inhibitor
0,473  0,012  Interleukin 2 agonist
0,474  0,014  Antidiabetic symptomatic
0,455  0,004  Hexokinase inhibitor
0,476  0,027  Antineoplastic (melanoma)
0,473  0,025  Analeptic
0,450  0,003  Antiviral (Influenza B)
0,456  0,014  Antineoplastic (liver cancer)
0,469  0,031  Antineoplastic (ovarian cancer)
0,439  0,004  UDP-glucose 4-epimerase inhibitor
0,444  0,016  Antineoplastic enhancer
0,436  0,011  Antiviral (Herpes)
0,430  0,008  Antiviral (Influenza)
0,430  0,015  Interleukin agonist
0,415  0,003  Selectin antagonist
0,439  0,029  Antineoplastic (glioma)
0,413  0,005  Expectorant
0,415  0,008  Alpha-N-acetylglucosaminidase inhibitor
0,419  0,014  P-glycoprotein inhibitor
0,409  0,005  Topoisomerase I inhibitor
0,434  0,035  Immunomodulator
0,432  0,034  CYP1A2 substrate
0,410  0,015  Septic shock treatment
0,428  0,033  Antiischemic
0,404  0,010  DNA methylase inhibitor
0,456  0,066  Alzheimer's disease treatment
0,402  0,011  Antineoplastic (squamous cell carcinoma)
0,393  0,005  SULT1A3 substrate
0,383  0,004  Carbonic anhydrase VI inhibitor
0,381  0,010  DNA methyltransferase I inhibitor
0,381  0,013  UGT1A3 substrate
0,370  0,003  Photosensitizer
0,372  0,006  Psychosexual dysfunction treatment
0,394  0,033  Antineoplastic (non-small cell lung cancer)
0,362  0,003  Antiviral (Ebola)
0,381  0,024  Antineoplastic (small cell lung cancer)
0,360  0,005  NADH dehydrogenase inhibitor
0,359  0,005  Topoisomerase II alpha inhibitor
0,358  0,004  Choleretic
0,354  0,008  Insulin secretagoues
0,360  0,014  Antipruritic, non-allergic
0,352  0,008  Glutathione S-transferase substrate
0,350  0,007  NADPH oxidase inhibitor
0,349  0,006  Antiprotozoal (Coccidial)
0,377  0,036  CYP1A2 inhibitor
0,351  0,011  Antiviral (Influenza A)
0,349  0,012  Peptidyltransferase inhibitor
0,393  0,057  Vasodilator, peripheral
0,348  0,012  Antineoplastic (gastric cancer)
0,345  0,010  Antihelmintic (Nematodes)
0,341  0,007  Carcinogenic, group 1
0,387  0,053  Bone diseases treatment
0,367  0,033  Antineoplastic (glioblastoma multiforme)
0,375  0,043  Antiosteoporotic
0,339  0,008  Cell wall synthesis inhibitor
0,342  0,013  Muscular dystrophy treatment
0,336  0,010  Acute respiratory distress syndrome (ARDS) treatment
0,334  0,011  Interleukin 6 antagonist
0,338  0,017  Antineoplastic (carcinoma)
0,324  0,004  Histone deacetylase SIRT1 stimulant
0,324  0,004  Histone deacetylase stimulant
0,328  0,008  Carcinogenic, group 2B
0,322  0,006  Dementia treatment
0,352  0,035  Antineoplastic (renal cancer)
0,388  0,074  Antiprotozoal
0,412  0,098  Antineoplastic (solid tumors)
0,319  0,006  Vascular dementia treatment
0,363  0,051  Antimycobacterial
0,380  0,073  CYP2C19 inhibitor
0,310  0,005  Mannose-6-phosphate isomerase inhibitor
0,308  0,005  ATPase inhibitor
0,311  0,009  Antineoplastic antibiotic
0,345  0,043  Antineoplastic (multiple myeloma)
0,356  0,055  CYP2D6 substrate
0,320  0,021  Thrombolytic
0,328  0,034  Antiulcerative
0,345  0,054  Lipoprotein disorders treatment
0,291  0,005  Aldose reductase inhibitor
0,298  0,012  Alkaline phosphatase inhibitor
0,286  0,005  Triose-phosphate isomerase inhibitor
0,302  0,021  Carcinogenic, group 3
0,289  0,010  Gout treatment
0,350  0,071  Angiogenesis inhibitor
0,283  0,005  Alcohol dehydrogenase inhibitor
0,277  0,004  Carbonic anhydrase XIV inhibitor
0,323  0,050  Antineoplastic (endocrine cancer)
0,310  0,039  Antineoplastic (bladder cancer)
0,274  0,005  Creatine kinase inhibitor
0,280  0,013  DNA polymerase I inhibitor
0,270  0,007  SULT1A1 substrate
0,291  0,028  UGT2B7 substrate
0,263  0,003  Phosphodiesterase 6D inhibitor
0,272  0,016  Antidiarrheal
0,256  0,010  Retinoprotector
0,306  0,059  Aryl hydrocarbon receptor agonist
0,251  0,006  CF transmembrane conductance regulator agonist
0,250  0,007  Uric acid excretion stimulant
0,266  0,026  Insulin sensitizer
0,272  0,036  UGT1A4 substrate
0,243  0,010  Antispirochetal
0,238  0,005  Chronic obstructive bronchitis treatment
0,238  0,005  Thioredoxin inhibitor
0,260  0,028  Protein-tyrosine phosphatase inhibitor
0,351  0,119  Antiarthritic
0,235  0,004  Heat shock protein 70 antagonist
0,239  0,009  Antineoplastic, alkylator
0,272  0,042  Wound healing agent
0,237  0,008  Phosphofructokinase-1 inhibitor
0,327  0,099  GABA C receptor rho-3 antagonist
0,238  0,011  Antifungal (Cryptococcus)
0,243  0,017  Chelator
0,247  0,027  Liver fibrosis treatment
0,274  0,054  Antineoplastic (lymphocytic leukemia)
0,220  0,003  Antibiotic Glycopeptide-like
0,217  0,001  Sodium/glucose cotransporter inhibitor
0,225  0,011  Antibiotic
0,281  0,069  Huntington's disease treatment
0,256  0,046  Peroxidase inhibitor
0,215  0,008  Multidrug resistance-associated protein 1 inhibitor
0,246  0,039  Diabetic retinopathy treatment
0,215  0,009  Gastritis treatment
0,222  0,019  Antirickettsial
0,205  0,005  Carbonic anhydrase VII inhibitor
0,211  0,011  Mucolytic
0,250  0,050  Sedative
0,274  0,074  Aldehyde oxidase inhibitor
0,214  0,015  Anticataract
0,203  0,004  Fatty acid synthase inhibitor
0,204  0,005  Toll-Like receptor 4 antagonist
0,236  0,038  Antiviral (Hepatitis)
0,221  0,024  Protein-tyrosine phosphatase 1B inhibitor
0,244  0,049  Antialcoholic
0,232  0,037  Diabetic nephropathy treatment
0,328  0,134  Calcium channel L-type activator
0,262  0,075  Antiprotozoal (Trypanosoma)
0,220  0,032  VEGF expression inhibitor
0,196  0,009  Transcription factor NF kappa B stimulant
0,197  0,010  Sphingomyelinase inhibitor
0,195  0,010  Carcinogenic, group 2A
0,208  0,024  DNA intercalator
0,189  0,005  Xanthine dehydrogenase inhibitor
0,177  0,002  Cholesterol absorption inhibitor
0,188  0,013  Antineoplastic (uterine cancer)
0,184  0,011  NAD(P)H dehydrogenase (quinone) inhibitor
0,199  0,029  MAO A inhibitor
0,244  0,075  Platelet antagonist
0,187  0,018  UGT2B1 substrate
0,217  0,050  Sepsis treatment
0,232  0,067  Antiviral (HIV)
0,283  0,120  Antineoplastic (non-Hodgkin's lymphoma)
0,165  0,002  Sodium/glucose cotransporter 1 inhibitor
0,203  0,040  Neuropathy treatment
0,237  0,074  Hypolipemic
0,167  0,005  Phosphodiesterase VI inhibitor
0,171  0,010  Postmenopausal disorders treatment
0,259  0,098  Metabolic disease treatment
0,169  0,008  Interleukin 12 antagonist
0,228  0,068  Pyruvate kinase inhibitor
0,189  0,030  Antiviral (Hepatitis B)
0,159  0,001  Sodium/glucose cotransporter 2 inhibitor
0,190  0,036  Acetylcholinesterase inhibitor
0,179  0,029  Antibacterial (Helicobacter pylori)
0,156  0,007  Antiviral (Dengue virus)
0,180  0,031  Cell adhesion inhibitor
0,179  0,030  Adenylate cyclase inhibitor
0,221  0,073  Interleukin antagonist
0,193  0,045  Antineoplastic (bone cancer)
0,160  0,013  HIV-1 integrase (3'-Processing) inhibitor
0,187  0,040  Antidiabetic (type 1)
0,158  0,012  Carbonic anhydrase XII inhibitor
0,175  0,030  Adenylate cyclase stimulant
0,204  0,059  Dual specificity phosphatase 3 inhibitor
0,147  0,004  Antimycoplasmal
0,153  0,011  Estrogen agonist
0,149  0,007  Neuraminidase (influenza) inhibitor
0,144  0,004  Alpha-mannosidase inhibitor
0,154  0,014  SULT1E1 substrate
0,149  0,010  Interferon agonist
0,195  0,057  Dual specificity phosphatase inhibitor
0,164  0,027  Vanilloid 1 agonist
0,145  0,007  Na+ K+ transporting ATPase inhibitor
0,150  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,140  0,004  Mannosidase inhibitor
0,156  0,021  Estrogen antagonist
0,137  0,005  Topoisomerase II beta inhibitor
0,234  0,101  Antituberculosic
0,137  0,008  Phosphorylase inhibitor
0,182  0,054  Cystic fibrosis treatment
0,160  0,034  Beta amyloid protein antagonist
0,160  0,034  Growth stimulant
0,126  0,003  Arginase inhibitor
0,179  0,056  UGT2B10 substrate
0,137  0,015  CDC25A inhibitor
0,133  0,012  T cell inhibitor
0,128  0,010  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,179  0,062  Phospholipase C inhibitor
0,134  0,016  Interleukin 5 antagonist
0,131  0,014  ATPase (Vacuolar H+) inhibitor
0,139  0,024  Actinic keratosis treatment
0,175  0,061  Restenosis treatment
0,171  0,057  Hair growth stimulant
0,122  0,009  Neuraminidase inhibitor
0,169  0,059  UGT2B9 substrate
0,113  0,004  Glucose-6-phosphate isomerase inhibitor
0,132  0,025  Aminoacyl-tRNA synthetase inhibitor
0,219  0,113  Transcription factor STAT inhibitor
0,222  0,120  Lipoxygenase inhibitor
0,158  0,056  Hearing loss treatment
0,105  0,004  Heparanase inhibitor
0,119  0,018  Lipase inhibitor
0,154  0,054  Cyclooxygenase 1 inhibitor
0,230  0,132  GST M1-1 substrate
0,101  0,003  Antibiotic Aminoglycoside-like
0,109  0,011  Protein 50S ribosomal subunit inhibitor
0,243  0,146  Antiprotozoal (Plasmodium)
0,254  0,160  Atherosclerosis treatment
0,147  0,055  Toll-Like receptor 2 antagonist
0,156  0,065  Cyclooxygenase inhibitor
0,164  0,072  Antiviral (Hepatitis C)
0,151  0,060  MAO inhibitor
0,126  0,035  Breast cancer-resistant protein inhibitor
0,105  0,015  Antidote, heavy metal
0,178  0,088  Anesthetic general
0,122  0,033  UGT2B11 substrate
0,091  0,003  Protein 30S ribosomal subunit inhibitor
0,100  0,013  Interferon inducer
0,108  0,022  Thioredoxin reductase inhibitor
0,123  0,037  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,115  0,032  Antiviral (Rhinovirus)
0,091  0,008  Glucose-6-phosphate translocase inhibitor
0,258  0,177  Antiparkinsonian
0,107  0,027  Glycine receptor antagonist
0,115  0,038  Estrogen receptor beta antagonist
0,132  0,055  Cholesterol synthesis inhibitor
0,114  0,037  Arylamine N-Acetyltransferase substrate
0,080  0,004  Nucleoside transporters inhibitor
0,151  0,078  Eye irritation, high
0,135  0,062  Antihyperlipoproteinemic
0,109  0,035  Ornithine decarboxylase inhibitor
0,140  0,066  Antiacne
0,141  0,068  Neurotrophic factor
0,093  0,021  Antitreponemal
0,087  0,016  Nitric oxide donor
0,107  0,036  Restless leg syndrome treatment
0,148  0,077  GABA C receptor rho-2 antagonist
0,090  0,021  Maillard reaction inhibitor
0,134  0,067  Cyclooxygenase 2 inhibitor
0,096  0,028  Narcotic antagonist
0,102  0,037  Antiviral (Trachoma)
0,116  0,050  DOPA decarboxylase inhibitor
0,206  0,141  5 Hydroxytryptamine uptake stimulant
0,245  0,180  Antineoplastic (myeloid leukemia)
0,122  0,058  Microtubule formation inhibitor
0,076  0,015  Estrogen receptor beta agonist
0,066  0,009  Neuraminidase (Influenza A) inhibitor
0,129  0,072  Tubulin antagonist
0,068  0,015  Adenosine deaminase inhibitor
0,071  0,019  Leukotriene B4 antagonist
0,138  0,087  Diuretic
0,111  0,061  Electron transport complex I inhibitor
0,137  0,087  Ca2+-transporting ATPase inhibitor
0,116  0,067  Transcription factor STAT6 inhibitor
0,087  0,038  Histidine decarboxylase inhibitor
0,064  0,015  Equilibrative nucleoside transport protein inhibitor
0,078  0,029  CDC25B inhibitor
0,108  0,061  HDL-cholesterol increasing
0,106  0,059  Carbonic anhydrase XV inhibitor
0,085  0,041  Estrogen receptor alpha antagonist
0,047  0,003  Vanilloid 2 agonist
0,080  0,038  HIV-1 integrase inhibitor
0,084  0,042  Telomerase inhibitor
0,064  0,022  Adenine nucleotide translocase inhibitor
0,116  0,074  M18 aspartyl aminopeptidase inhibitor
0,059  0,018  Cholesterol esterase inhibitor
0,096  0,057  Falcipain inhibitor
0,095  0,056  Falcipain 2 inhibitor
0,059  0,022  Antiviral (Herpesvirus 3, Human)
0,045  0,010  Uridine phosphorylase inhibitor
0,119  0,085  Papain-like protease (SARS coronavirus) inhibitor
0,158  0,125  Growth factor agonist
0,092  0,061  Protein kinase C zeta inhibitor
0,117  0,087  Contraceptive
0,062  0,032  Lipocortins synthesis agonist
0,047  0,018  Estrogen receptor alpha agonist
0,031  0,003  Telomerase stimulant
0,054  0,026  Factor III inhibitor
0,070  0,043  Gaucher disease treatment
0,028  0,004  Antibiotic Anthracycline-like
0,033  0,009  Toll-Like receptor 4 agonist
0,104  0,081  TRPA1 agonist
0,051  0,028  Cytokine production stimulant
0,144  0,122  Psychostimulant
0,129  0,108  Antinephritic
0,032  0,011  1,3-Beta-glucan synthase inhibitor
0,088  0,068  Glutamate release inhibitor
0,028  0,010  Dopamine D1 agonist
0,064  0,046  Leukotriene antagonist
0,185  0,168  12-Lipoxygenase inhibitor
0,034  0,020  Estrogen-related receptor beta antagonist
0,025  0,012  GRP78 expression inhibitor
0,053  0,040  Protein kinase C eta inhibitor
0,078  0,065  Glutathione S-transferase inhibitor
0,115  0,101  Acaricide
0,113  0,100  Interleukin 1 antagonist
0,062  0,050  Aryl hydrocarbon receptor antagonist
0,064  0,053  Carbonic anhydrase VA inhibitor
0,026  0,015  Adenosine A1 receptor agonist
0,052  0,042  Carbonic anhydrase IX inhibitor
0,085  0,075  5-Lipoxygenase inhibitor
0,106  0,096  Alcohol dehydrogenase substrate
0,050  0,041  Alpha tubulin antagonist
0,048  0,039  Squalene epoxidase inhibitor
0,080  0,071  Vanilloid agonist
0,032  0,024  Melatonin 2 agonist
0,100  0,094  Neutropenia treatment
0,117  0,111  Cholinergic
0,030  0,025  ATP citrate lysase inhibitor
0,011  0,007  Purinergic P2Y2 agonist
0,053  0,052  Carbonic anhydrase inhibitor
0,032  0,032  Ceramide glucosyltransferase inhibitor

